(Q50958782)

English

Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.

scientific article published on 24 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Akio Monji

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Toko Mitsui

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Morihiko Aoyama

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Toshimasa Shigeta

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Toyoaki Murohara

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

24 May 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

305

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

H295-304

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23709595%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic review

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Diabetic cardiomyopathy revisited

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Exenatide exerts a potent antiinflammatory effect

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Peroxisome proliferator-activated receptor-γ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Regulation of myocardial growth and death by NADPH oxidase

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

GLP-1 receptor agonists: a clinical perspective on cardiovascular effects

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Mitochondrial reactive oxygen species drive proinflammatory cytokine production

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

ICAM-1 cytoplasmic tail regulates endothelial glutathione synthesis through a NOX4/PI3-kinase-dependent pathway.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Lipotoxicity: when tissues overeat

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Insulin sensitivity: modulation by nutrients and inflammation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Lipotoxicity in type 2 diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishme

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Obesity, inflammation, and insulin resistance--a mini-review

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00990.2012

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50958782&oldid=1586548317"